A Phase II Study of Paclitaxel/Cisplatin Combination in Patients with Metastatic Breast Cancer Refractory to Anthracycline-Based ChemotherapyGerardo Rosati, G Pacilio, Ferdinando Riccardi et al.|Tumori Journal|2000Cited by 17
Phase II trial of paclitaxel (P) and cisplatin (COOP) in patients with advanced breast cancer refractory to anthracycline (A) therapyFerdinando Riccardi, G Pacilio, G. Rosati et al.|European Journal of Cancer|1997Cited by 1